About Rodin Therapeutics
Rodin Therapeutics is a company based in Cambridge (United States) founded in 2013 was acquired by Alkermes in November 2019. Rodin Therapeutics has raised $57.2 million across 5 funding rounds from investors including Biogen, Alkermes and HHS. The company has 13 employees as of December 31, 2022. Rodin Therapeutics operates in a competitive market with competitors including Jazz Pharmaceuticals, Biogen, Neurocrine, PTC Therapeutics and Biohaven Pharmaceutical, among others.
- Headquarter Cambridge, United States
- Employees 13 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Rodin Therapeutics, Inc
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Rodin Therapeutics
Rodin Therapeutics has successfully raised a total of $57.2M across 5 strategic funding rounds. The most recent funding activity was a Series C round of $27 million completed in September 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Rodin Therapeutics
Rodin Therapeutics has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include Biogen, Alkermes and HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm investing in life science and biotechnology sectors
|
Locked | Locked | Locked | |
|
Corporate backed venture capital fund investing in multiple sectors
|
Locked | Locked | Locked | |
|
Tech & Life Sciences focused VC firm investing in early stage companies in the US & Europe
|
Locked | Locked | Locked |
Investor details for Rodin Therapeutics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Rodin Therapeutics
Investment portfolio details for Rodin Therapeutics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Rodin Therapeutics
Detailed financials for Rodin Therapeutics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Rodin Therapeutics Comparisons
Peer comparison for Rodin Therapeutics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Rodin Therapeutics
Rodin Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, Biogen, Neurocrine, PTC Therapeutics and Biohaven Pharmaceutical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| Locked | Locked | Locked |
Therapies for neurodegenerative and immunology disorders are developed.
|
|
| Locked | Locked | Locked |
Developer of small molecule therapeutics for endocrine and CNS disorders
|
|
| Locked | Locked | Locked |
Small molecule drugs for rare diseases are developed.
|
|
| Locked | Locked | Locked |
Therapies for neurological and neuropsychiatric diseases are developed.
|
|
| Locked | Locked | Locked |
Gene and protein therapies are developed for treating various diseases.
|
Detailed competitors of Rodin Therapeutics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Rodin Therapeutics
Complete news archive for Rodin Therapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rodin Therapeutics
Rodin Therapeutics was founded in 2013.
Rodin Therapeutics is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Rodin Therapeutics is a funded company, having raised a total of $57.2M across 5 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Rodin Therapeutics is 13.
Rodin Therapeutics was founded in 2013 and is headquartered in Cambridge, United States. Focus is placed on the biotechnology sector, where epigenetic modulators are developed for addressing central nervous system disorders. Epigenetic regulation is achieved through HDAC complex modulation, by which synaptic function, neuronal health, and survival are restored in degenerative brain diseases. Operations center on research and therapeutic development in this field.
Rodin Therapeutics's top competitors include Jazz Pharmaceuticals, PTC Therapeutics and Neurocrine.
Rodin Therapeutics has 9 investors. Key investors include Biogen, Alkermes, HHS, Atlas Venture, and Google Ventures.